Hip fractures occur more than 250,000 times each year in the US and over 1.6 million times each year worldwide.

The REGAIN clinical research trial is designed to determine whether one type of standard care anesthesia given to patients undergoing surgery for a hip fracture leads to better outcomes in recovery of walking, overall health and disability, pain, and survival.  Read more...

clinicaltrials.gov  NCT 02507505